Enzene, Inc.
Enzene Biosciences is a global CDMO and biosimilar developer dedicated to bringing trusted and affordable medicines to market quickly. They have revolutionized biologics production with their patented continuous bioprocess manufacturing platform, EnzeneX™, which reduces production costs of complex biologics and monoclonal antibodies. Their fully-integrated services and biosimilars pipeline cater to every project need, with established facilities in India and a new development near Princeton, New Jersey, USA. The company is committed to continuous innovation, leveraging advanced technologies like EnzeneX™ and EnzeneX™ 2.0, and expanding its global footprint with new facilities. Enzene offers comprehensive solutions across drug discovery, development, manufacturing, analytical/CMC, and modalities, supported by regulatory services and biosimilar pipelines. Their mission is to impact global healthcare by providing trusted, affordable medicines at speed.
Industries
Nr. of Employees
large (251-1000)
Enzene, Inc.
Plot No. A 22, A/1/2 Chakan Industrial Area, Phase 2, Khalumbre, Chakan, Pune, Maharashtra - 410501
Patents
Fusion tags and expression vector system for the expression of human parathyroid hormone (rhPTH)
US-9580488-B2
View Details
Fusion tags and expression vector system for the expression of human parathyroid hormone (rhPTH)
US-9580488-B2
View DetailsProducts
GMP Compliant Manufacturing
Develops GMP processes for mAbs and complex biologics, including mammalian-based perfusion and fed-batch processes, and a dedicated E. coli manufacturing unit.
Custom Peptide Synthesis
Offers solid-state and liquid-state manufacturing of custom peptide synthesis with purification technologies for complex therapeutic peptides.
Analytical Testing for Peptides
Provides comprehensive analytical testing for peptides using UPLC and Mass spec to ensure purity and characterization.
Cell Line Engineering
Invests in technologies for cell line engineering to support drug product development.
Biosimilar Pipeline
Maintains a strong clinical and biosimilar pipeline with multiple products nearing launch for the Indian and global markets.
GMP Compliant Manufacturing
Develops GMP processes for mAbs and complex biologics, including mammalian-based perfusion and fed-batch processes, and a dedicated E. coli manufacturing unit.
Custom Peptide Synthesis
Offers solid-state and liquid-state manufacturing of custom peptide synthesis with purification technologies for complex therapeutic peptides.
Analytical Testing for Peptides
Provides comprehensive analytical testing for peptides using UPLC and Mass spec to ensure purity and characterization.
Cell Line Engineering
Invests in technologies for cell line engineering to support drug product development.
Biosimilar Pipeline
Maintains a strong clinical and biosimilar pipeline with multiple products nearing launch for the Indian and global markets.
Services
A comprehensive suite of discovery solutions tailored to bring groundbreaking therapies to market efficiently.
Solutions designed to support biologics journey from cell line engineering to formulation, providing a seamless route to market.
Manufacturing services using fed-batch processes and EnzeneX™ continuous platform, designed to meet current and future needs.
Expertise spanning monoclonal antibodies, recombinant proteins, conjugated proteins, bispecifics, fusion proteins, synthetic peptides, pDNA, and phytopharmaceuticals.
A comprehensive suite of discovery solutions tailored to bring groundbreaking therapies to market efficiently.
Solutions designed to support biologics journey from cell line engineering to formulation, providing a seamless route to market.
Manufacturing services using fed-batch processes and EnzeneX™ continuous platform, designed to meet current and future needs.
Expertise spanning monoclonal antibodies, recombinant proteins, conjugated proteins, bispecifics, fusion proteins, synthetic peptides, pDNA, and phytopharmaceuticals.
News & Updates
Meet Enzene at the Animal Health Corridor Summit to explore strategic CDMO support for veterinary biologics.
Enzene will attend BPS 2025 and connect with biopharmaceutical organizations seeking CDMO partnerships.
Enzene offers support for human and animal health biologics at the Nordic Life Science Days.
Enzene will participate in CPHI Worldwide 2025 to engage with global partners.
Enzene announced that its two facilities in Pune have obtained EU-GMP certification.
Enzene launched Ranibizumab, a biosimilar to Lucentis®, for eye treatments.
Meet Enzene at the Animal Health Corridor Summit to explore strategic CDMO support for veterinary biologics.
Enzene will attend BPS 2025 and connect with biopharmaceutical organizations seeking CDMO partnerships.
Enzene offers support for human and animal health biologics at the Nordic Life Science Days.
Enzene will participate in CPHI Worldwide 2025 to engage with global partners.
Enzene announced that its two facilities in Pune have obtained EU-GMP certification.
Enzene launched Ranibizumab, a biosimilar to Lucentis®, for eye treatments.